List of Lusedra drug patents

Lusedra is owned by Eisai Inc.

Lusedra contains Fospropofol Disodium.

Lusedra has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Lusedra are:

  • US6204257

Lusedra was authorised for market use on 12 December, 2008.

Lusedra is available in solution;intravenous dosage forms.

Lusedra can be used as sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation.

The generics of Lusedra are possible to be released after 01 July, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6204257 EISAI INC Water soluble prodrugs of hindered alcohols
Jul, 2022

(9 months ago)

Drugs and Companies using FOSPROPOFOL DISODIUM ingredient

Market Authorisation Date: 12 December, 2008

Treatment: Sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic